sa.ivaturi
Submits third-party assay reports on material purchased directly. Based in Plovdiv.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.51%
n=10
Suppliers covered
9
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043598 | Tesamorelin | PPG | PPG-2608-A6835 | Kestrel | 2026-Q3 | 98.91 | 2.56 | 100.3 | Buyer-sourced | 1 | FAIL |
| AX-2026-042734 | Tirzepatide | GGPeps | GGPE-2604-H1052 | Medutest | 2026-Q2 | 99.56 | 1.79 | — | Buyer-sourced | 0 | PASS |
| AX-2026-042099 | Semax | JEEP | JEEP-2602-C8195 | Janoshik | 2026-Q1 | 99.53 | 8.28 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018988 | Enclomiphene citrate | ASY | ASY-{CAT}-1806 | Janoshik | 2025-Q4 | 99.56 | 3.61 | — | Buyer-sourced | 2 | FAIL |
| AX-2025-020562 | Semaglutide | SSA | SSA-2509-J7377 | Janoshik | 2025-Q4 | 97.67 | 6.96 | 88.7 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-020159 | Ipamorelin | ERP | ERP-2502-S9437 | Medutest | 2025-Q3 | 99.67 | 4.25 | 91.0 | Buyer-sourced | 0 | PASS |
| AX-2025-020466 | GHRP-6 | KP | KP-2503-L5154 | Medutest | 2025-Q3 | 98.54 | 3.84 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-019757 | Semaglutide | Homopeptide | HOMO-2501-D4523 | Janoshik | 2025-Q1 | 99.49 | 5.48 | 90.8 | Buyer-sourced | 0 | PASS |
| AX-2024-004513 | Exenatide | HYB | HYB-2407-J6692 | Janoshik | 2024-Q3 | 98.74 | 3.93 | 92.0 | Buyer-sourced | 0 | PASS |
| AX-2024-004898 | Gonadorelin | ERP | ERP-2406-C9933 | Janoshik | 2024-Q3 | 99.70 | 3.54 | 92.1 | Buyer-sourced | 0 | PASS |